CD276 and neoplasm: However, when CAR T cells were repeatedly challenged with tumor cells, GPC2-CARs showed reduced cytotoxicity compared to GD2- and B7-H3-CARs, particularly against D283 cells (Figures 2E and 2F; Figures S6A and S6B).